PP
MYOV

Paloma Partners’s Myovant Sciences Ltd. MYOV Stock Holding History

Paloma Partners’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,131
Closed -$373K – 2431
2021
Q1 		$373K Buy
+18,131
New +$413K 0.01% 1342
2020
Q1 		– Sell
-10,584
Closed -$164K – 2270
2019
Q4 		$164K Buy
+10,584
New +$107K ﹤0.01% 2005
2017
Q3 		– Sell
-39,565
Closed -$463K – 2543
2017
Q2 		$463K Buy
+39,565
New +$490K 0.01% 1591

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Paloma Partners's MYOV Position: Q2 2021 in Review

Paloma Partners sold out of Myovant Sciences Ltd. (MYOV) in Q2 2021, closing a stake of 18,131 shares — an estimated $373K sold.

Paloma Partners first reported a position in MYOV in Q2 2017 and held it in 3 quarters. The position peaked at $463K in Q2 2017. 108 funds tracked by Wall St. Rank hold MYOV as of Q2 2021.

  • Paloma Partners reported no remaining Myovant Sciences Ltd. position as of Q2 2021 after selling out during the quarter.
  • Paloma Partners sold 18,131 Myovant Sciences Ltd. shares in Q2 2021, an estimated $373K.
  • Paloma Partners first reported a position in Myovant Sciences Ltd. in Q2 2017 and held it in 3 quarters.
  • Paloma Partners's Myovant Sciences Ltd. position peaked at $463K in Q2 2017.
  • 108 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2021.

Based on Paloma Partners's 13F filing for Q2 2021, filed 16 Aug 2021.